Cures Act Left Drug-Device Distinction Murky, Panel Says

The 21st Century Cures Act represents a “missed opportunity” to clarify the distinction between a drug and a device and improve transparency, according to experts at a June 8 conference sponsored by FDAnews in Washington D.C. Thursday on combination products.
Source: Drug Industry Daily